Notice	Director’s Report	Management Discussion	Report on Corporate	Auditor’s Report
Balance Sheet	Profit and Loss	Notes Forming	Case Flow	Proxy Form

---

COLINZ LABORATORIES LTD.

NOTES  FORMING PART OF THE FINANCIAL STATEMENTS

		All amounts in Rupees, unless otherwise stated
		As at		As at
		March 31, 2012		March 31, 2011
Notes 1 - Share Capital
a	Authorised:
	60,00,000 (Previous Year 60,00,000) Equity Shares of Rs.10 each	60,000,000		60,000,000
b	Issued, Subscribed and Paid-up:
	Issued:
	45,76,000 Equity shares of Rs. 10 each.
	Subscribed and paid-up:
	45,71,000 (Previous Year 45,71,000) Equity Shares of Rs.	35,435,000		35,435,000
	10 each fully/Partly  paid-up	35,435,000		35,435,000
c	Par Value per share is Rs. 10
d	Reconciliation of the number of shares outstanding at the beginning and at the end of the reporting period;
	Particulars	No.	Rs.	No.	Rs.
	Shares outstanding at the beginning of the year	3543500	35,435,000	3543500	35,435,000
	Shares Issued during the year	0	0	0	0
	Shares bought back during the year	0	0	0	0
	Any other movement (please specify)	0	0	0	0
	Shares outstanding at the end of the year	3543500	35,435,000	3543500	35,435,000
e	shares in the company held by each shareholder holding more than 5 percent shares specifying the number of shares held
	Name of the shareholder	No. of shares	% of holding	No. of shares	% of holding
	L S Mani	705050	15.4244	705050	15.4244
	Vijaya Mani	386000	8.4445	208750	4.5668
f	For the period of five years immediately preceding the date as at which the Balance Sheet is prepared:	Aggregate No. of Shares (for last 5 Financial Years)
	Particulars
	Fully paid up pursuant to contract(s) without payment being received in cash	Nil
	Fully paid up by way of bonus shares	Nil
	Shares bought back	Nil
g	Unpaid Calls	No. of shares	Rs.	No. of shares	Rs.
	By Directors	0	0	0	0
	By Officers	0	0	0	0
	By Others	2055000	10,275,000	2055000	10,275,000
Notes 2 - Reserves & Surplus
a.	Capital Reserves:
	State Special Capital Incentive Received	Rs.	Rs.	Rs.	Rs.
	Opening Balance	3,100,000		2,700,000
	(+) Current Year Transfer	400,000		400,000
	(-)  Written back in the current year	0		0
	Closing balance		3,500,000		3,100,000
b.	Share Premium Account
	Opening Balance	15,220,250		15,220,250
	(+) Current Year Transfer	0		0
	(-)  Written back in the current year	0		0
	Closing balance		15,220,250		15220250
c.	Profit & Loss Account
	Opening Balance	6,526,010		5,797,184
	(+) Current Year Transfer	1,104,250		728,826
	(-)  Transfer to Other Reserves	0		0
	Closing balance		7,630,260		6,526,010
	Total [a+b+c]		26,350,510		24,846,260

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES  FORMING PART OF THE FINANCIAL STATEMENTS

		All amounts in Rupees, unless otherwise stated
		As at	Total As at
		March 31, 2012	March 31, 2011
Notes 3 - Long Term Borrowings
	Secured-From Banks
	Cash Credit Account with Bank of Baroda	8,794,822	11,591,998
	[Secured by Hypothecation of Stock in Trade/Book debts]
	Term loan from Bank of Baroda	-	1,394,146
	[Secured by hypothecation of plant and machinery at Sinnar
	factory]
	Car Loan from Axis Bank	712,898	97,502
	[Secured against hypothecation of car]
		9,507,720	13,083,646
	Unsecured Loans -Others
	Sales tax deferred (Interest free)	14,410,131	15,382,815
	[As per Package Scheme of Incentive of Maharashtra state
	government and includes VAT and CST]
		14,410,131	15,382,815
	Total	23,917,851	28,466,461
Notes 4- Trade Payables
	Sundry Creditors:
	a) Micro and small enterprises *	-	-
	b) Others	9,216,354	6,630,085
	* [Determined to the extent such particulars have been identified
	on the basis of information available with the Company. This has
	been relied upon by the auditors]
		9,216,354	6,630,085
Notes 5- Other Current Liabilities
	Statutory liabilities	875,131	743,958
	Other Liabilities	2,651,184	1,787,600
	Provisions	530,453	505,522
		4,056,768	3,037,080

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES FORMING PART OF THE BALANCE SHEET AS AT MARCH 31, 2012

Notes 6 - Fixed Assets

DESCRIPTION	GROSS BLOCK				DEPRECIATION				NET BLOCK
	As at 1.4.2011	Additon in	Deduction	As at 31.3.2012	As at 1.04.2011	Depreciation	Deduction	Up to 31.3.2012	As at 31.3.2012	As at 31.3.2011
		2011-12				for the year
A. Tangible Assets
LAND	2574350	0	0	2574350	0	0	0	0	2574350	2574350
[Including Land Developing Exps]
BUILDING- Factory	24027330	0	0	24027330	6696310	802513	0	7498823	16528507	17331020
BUILDING-Office	6580717	0	0	6580717	813898	107266	0	921164	5659553	5766819
PLANT & MACHINERY	11187512	0	0	11187512	5189574	531407	0	5720981	5466531	5997938
LABORATORY EQUIPMENTS	1570542	0	0	1570542	695390	74601	0	769991	800551	875152
FACTORY EQUIPMENTS & TOOLS	3223653	0	0	3223653	1289687	153124	0	1442811	1780842	1933966
ELECTRICAL INSTALLATION	2377531	0	0	2377531	1152252	112722	0	1264974	1112557	1225279
CENTRAL A.C. PLANT	8176691	0	0	8176691	2198075	388393	0	2586468	5590223	5978616
OFFICE EQUIPMENTS	592660	0	0	592660	380715	28151	0	408866	183794	211945
COMPUTER	644888	0	0	644888	578776	14220	0	592996	51892	66112
FURNITURE & FIXTURE	3469439	0	0	3469439	2054191	219616	0	2273807	1195633	1415248
VEHICLES	1544416	996363	605322	1935457	789970	167454	438305	519119	1416338	754446
Total Tangible Assets	65969729	996363	605322	66360770	21838838	2599467	438305	24000000	42360771	44130891
B. Intangible Assets	0	0	0	0	0	0	0	0	0	0
TOTAL ASSETS	65969729	996363	605322	66360770	21838838	2599467	438305	24000000	42360771	44130891
PREVIOUS YEAR	65913844	55885	0	65969729	19261313	2577525	0	21838838	44130891	46652531

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES FORMING PART OF THE FINANCIAL STATEMENTS

				All amounts in Rupees, unless otherwise stated
				As at	Total As at
		Face Value	No. of shares	March 31, 2012	March 31, 2011
Notes 7- Non-Current Investments
(a)   Equity shares [fully paid, quoted]
	3i Infotech	10	600	30000	30000
	Hubtown Ltd.	10	12	6480	6480
	Ansal Properties & Infrastructure Ltd.	5	200	101,926	101,926
	Arvind Mills	10	500	60681	60681
	Bajaj Holdings & Investments Ltd.	10	50	73319	73319
	Bajaj Auto  Ltd.	10	100	28678	28678
	Bajaj Finserv Ltd.	5	50	27770	27770
	Bank of Baroda	10	500	118534	118534
	Bank of Maharashtra	10	300	6900	6900
	Bell Ceramics	10	333	21880	21880
	Bharat Forge Ltd.	2	30	3804	3804
	Bharti Shipyard Ltd.	10	200	64841	64841
	Cairn India Ltd	10	1015	162400	162400
	CESC Ltd	10	200	128627	128627
	Coal India Ltd	10	88	21560	21560
	Eveready Industries Ltd.	5	500	17645	17645
	GTL Infrastructure Ltd	10	213	4000	4000
	Gujarat Sidhee Cement Ltd	10	1000	24186	24186
	HFCL Ltd.	1	500	12192	12192
	HDFC  Ltd.	2	100	64762	64762
	HDIL	10	100	14505	14505
	Hindustan Organic Chemicals Ltd	10	1000	66283	66283
	Hindustan Oil Exploration Co Ltd	10	500	81322	81322
	IDBI Ltd	10	200	15717	15717
	IDFC Ltd	10	2000	164446	164446
	Idea Cellular Ltd	10	990	130834	130834
	IRB Infrastructure  ltd	10	100	16457	16457
	Jagran Prakashan Ltd	2	143	27967	27967
	Kausalya Infrastructure Ltd	10	176	10560	10560
	Kingfisher Airlines	10	200	10641	10641
	Lanco Infrastructure Ltd	1	3210	77040	77040
	Macleod Russels Ltd	5	250	8823	8823
	Mahindra Lifespace Developers	10	200	184668	184668
	Maars Software Ltd	10	5000	57340	57340
	Morepen Laboratories Ltd.	2	500	7455	7455
	NTPC Ltd	10	500	71801	71801
	Neyveli Lignite Ltd.	10	400	22868	22868
	Panama Petrochem Ltd	10	250	32369	32369
	Polaris Software Lab Ltd.	5	200	32299	32299
	Punj Lloyd Ltd	2	500	99416	99416
	Pyramid Saimira Theatre Ltd	10	60	6000	6000
	Ranbaxy Labs. Ltd.	5	100	46004	46004
	Reliance Capital Ltd	10	10	1130	1130
	Reliance Communication Ltd	5	200	33654	33654
	Reliance  Infrastructure	10	15	6348	6348
	Reliance Power Ltd	10	74	7358	7358
	Simplex Infrastructure Ltd	2	200	76982	76982
	SeaMac	10	1000	192315	192315
	Sesa Goa	1	100	28407	28407
	Sonata Software Ltd	1	1000	52218	52218
	Spicejet Ltd	10	250	15138	15138
	Tamilnadu Petroproducts Ltd.	10	500	17290	17290
	Tanla Solutions Ltd	1	50	6625	6625
	Tata Tele (Mah) Services Ltd.	10	700	20634	20634
	Unitech Ltd	2	200	44887	44887
	United phosphorus	2	100	14083	14083
	Voltamp Transformers Ltd	10	100	63163	63163
	Wipro Ltd	2	83	13537	13537
	Total (a)			2,758,769	2,758,769
	[The market value of the quoted shares is Rs. 27,33,667/- ]
(a)   Mutual Funds & Others (Un-Quoted)
	UTI Master Value Fund	33.89	8852.169	300,000	300,000
	JM Infra & Agricultural Fund	10	10000	100,000	100,000
	Total (b)			400,000	400,000
	Total Investments [a+b]			3,158,769	3,158,769

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES FORMING PART OF THE FINANCIAL STATEMENTS

		All amounts in Rupees, unless otherwise stated
		As at	Total As at
		March 31, 2012	March 31, 2011
Notes 8 - Long Term Loans & Advances
	Security Deposits	713,150	709,150
	Loans to Companies	13,050,000	13,250,000
		13,763,150	13,959,150
Notes 9- Other Non-Current Assets
	Cash and Cash Equivalants
	Fixed Deposits maturing after 12 months	524,850	-
		524,850	-
Notes 10 - Inventories
	Raw Materials [Valued at the lower of cost (first in first out) and estimated net realisable value]	2,468,041	1,604,693
	Packing Materials [Valued at the lower of cost (first in first out) and estimated net realisable value]	1,339,510	992,729
	Work-in-Progress [Valued at the lower of cost and estimated net realisable value]	59,875	168,054
	Finished Goods [Valued at the lower of cost and estimated net realisable value]	17,465,638	16,262,247
		21,333,064	19,027,723
Notes 11 - Trade Receivables
	(Unsecured and considered good)
	Debts Outstanding For a Period Exceeding Six Months	1,243,083	1,340,585
	Other Debts	9,599,737	7,891,702
		10,842,820	9,232,287
	Trade Receivable stated above include debts due by:
	Directors *	-	-
	Other officers of the Company *	-	-
	Firm in which director is a partner *	-	-
	Private Company in which director is a member	-	-
	*Either severally or jointly
Notes 12 - Cash and Cash Equivalents
	Cash in Hand	358,547	390,818
	Balances with Banks on:
	-  Current Accounts	5,135,607	8,823,134
	-  Fixed Deposit Accounts	3,764,059	2,500,000
	Less: Restricted Cash	-	-
		9,258,213	11,713,952
Notes 13 - Short Term Loans and Advances
	(Unsecured and considered good, unless otherwise stated)
a	Loans and advances to related parties	-	-
b	Others
	Balances With Central Excise Authorities	53,999	47,897
	Advance to Employees	236,778	208,943
	Advance to Suppliers/Service Providers	-	-
	Pre-paid Expenses	141,001	178,970
	VAT Refund Receivable	304,075	180,338
	Tax Deducted at Source and Advance Tax	197,257	134,846
		933,110	750,994

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES FORMING PART OF THE FINANCIAL STATEMENTS

		All amounts in Rupees, unless otherwise stated
		Year ended	Year ended
		March 31, 2012	March 31, 2011
Notes 14 - Operating Revenue
	Sale of Products	70,454,561	60,336,549
		70,454,561	60,336,549
Notes 15 - Other Income
	Interest on:
	( - Bank Deposits [including tax deducted at source Rs.31,867 )	320,777	93,512
	(Previous year Rs. 15,281)]
	- Dividend	47,777	62,791
	Profit on Sale of shares	-	65,679
		368,554	221,982
Notes 16- Cost of Materials Consumed
	Opening Stock	2,597,421	3,047,824
	Add: Purchases	25,627,544	20,583,267
		28,224,965	23,631,091
	Less: Closing Stock	(3,807,551)	(2,597,421)
		24,417,414	21,033,670
Notes 17 -Changes in inventories of finished goods work-in-progress and Stock-in-Trade
	Opening Stock:
	- Finished Goods	16,262,247	13,368,881
	- Work-in-Progress	168,054	750,470
		16,430,301	14,119,351
	Less: Closing Stock:
	- Finished Goods	17,465,638	16,262,247
	- Work-in-Progress	59,875	168,054
		17,525,513	16,430,301
		(1,095,212)	(2,310,950)
Notes 18 - Employee Benefit Expense
	Salaries and Allowances	21,762,964	18,387,433
	Contribution to Provident and Other Funds	593,242	619,457
	Gratuity	187,400	40,800
		22,543,606	19,047,690

 

(Top)

---

COLINZ LABORATORIES LTD.

NOTES FORMING PART OF THE FINANCIAL STATEMENTS

		All amounts in Rupees, unless otherwise stated
		Year ended	Year ended
		March 31, 2012	March 31, 2011
Notes 19 - Finance Cost
	Interest Expences:	1,892,853	1,560,718
		1,892,853	1,560,718
Notes 20 - Other Expense
	Block & Designs	30,675	20,250
	Consumables	173,618	235,256
	Laboratory Expenses	92,405	108,400
	AC Rental Charges	175,848	132,778
	Office Rent	180,000	180,000
	Analytical Charges	288,708	223,745
	Office Expenses	572,832	587,384
	Conveyance	373,022	341,184
	Motor Car Expenses	171,898	181,939
	Factory Security Expenses	274,759	141,944
	Repairs and Maintenance:
	- Plant and Machinery	36,022	76,416
	- Building	269,474	-
	- Others	195,600	102,833
	Freight & Forwarding	1,390,682	1,396,225
	Insurance	116,670	90,071
	Loan License Charges Paid	1,312,568	1,349,788
	Auditors’ Remuneration	90,446	85,096
	Power & Fuel	710,954	690,907
	Printing & Stationery	105,900	65,758
	Books & Periodicals	30,000	19,100
	Postage & Telegram	345,243	263,182
	Legal & Professional Fees	413,242	599,037
	Loss on sale of assets	120,017	-
	Taxes & License Fees	318,568	367,538
	Society Maint. Charges	71,402	79,339
	Telephone Charges	439,975	263,352
	Travelling Expenses	614,895	1,218,260
	Commission on sales	927,386	912,993
	Directors' Remuneration	1,711,000	1,549,000
	Advertisement (Recruitment & Statutory)	119,903	204,648
	Water Charges	19,964	20,365
		11,693,676	11,506,788

 

(Top)

---

 

SCHEDULE 21: SIGNIFICANT ACCOUNTING POLICIES AND NOTES TO THE FINANCIAL STATEMENTS :-

a) Significant Accounting Policies:

i]   General :
The Financial statements are prepared under historical cost convention on an accrual basis and comply with the accounting standards referred to in Section 211 ( 3C ) of the Companies Act, 1956.

ii]  Fixed Assets:
Fixed assets are stated at original cost net of tax / duty credits availed, if any.

iii] Capital work in progress:
The capital work in progress as on 31-03-2012 is Rs. Nil

iv]  Depreciation :
Fixed Assets are depreciated under Straight Line Method. The applicable rates are as provided under Schedule XIV to the Companies Act, 1956. Depreciation on additions / deletions of  assets during the year is provided on a pro-rata basis.

v]  Inventories:
Raw materials and packing materials are valued at cost on FIFO basis as per revised Accounting Standard AS-2 of the Institute of Chartered Accountants of India. Finished goods and semi-finished goods are valued at lower of cost or net realizable value.

vi] Investments:
Investments are stated at cost.

vii] Sales:
Sales are recognized at the time of dispatch of goods. All sales are shown inclusive of excise duty and exclusive of Sales Tax (VAT).

viii] Other income:
Includes  interest on Fixed Deposits with Bank, dividends received and capital gains on the shares sold.

ix]  Research and Development Expenses:
No capitalization of Research and Development expenses is made since no capital expenditure on research and development expenditure has been incurred during the year.

x]  Foreign Currency Transactions:
Export earnings of Rs.Nil (Previous Year - Rs.NIL)
Foreign Exchange Outgo of Rs.NIL (Previous Year – Rs. NIL /-)

xi] Retirement Benefits:
Retirement benefit in respect of gratuity is not provided for, and liability is not         
ascertained.
Privilege leave entitlement: Privilege leave entitlements are recognized as a liability as and when the same is encashed by the employees.
Provident Fund: Contribution to Government provident Fund are made as per the provisions regularly.

b) The figures of previous year have been regrouped wherever necessary.

c) As per the available records, there is no outstanding dues to enterprises registered under Micro, Small and Medium Enterprises Development Act, 2006, at the end of the year. Further, no interest has been paid or payable on delayed payment of dues, if any, to such enterprises during the year

d) Estimated amount of contracts remaining to be executed on capital account and not provided for: Rs.Nil     [ Previous Year : Rs. Nil  ]

e) Contingent Liabilities:
Bills Discounted and Purchased  -  Rs. Nil (Previous Year Rs. Nil )
Others                                         -  Rs. Nil (Previous Year Rs. Nil )

f) Auditors Remuneration :                                                             

	2011-2012	2010-2011
Audit Fees	Rs.   66,180	Rs.   55,150
Tax Audit Fees	Rs.   11,030	Rs.   11,030
Other services	Rs.   13,236	Rs.   18,916
Total	Rs.   90,446	Rs.   85,096

 

g) Segment Reporting

The Company is engaged in pharmaceutical formulation business which as per Accounting Standard – AS 17 is considered the only reportable business segment.

h) Related party transaction

As required by Accounting Standard – AS 18 ‘Related Parties Disclosure’ issued by the Institute of Chartered Accountants of India are as follows :

   (a) Key Management personnel              (b)  Details of Transactions.
(i)  Dr. L. S. Mani.                                          Remuneration paid Rs.8,40,500/-
Rent paid for the premise hired Rs. 1,80,000/-

i) Earning per share

As per Accounting Standard – AS 20 on ‘Earning per Share’ issued by the Institute of Chartered Accountants of India, the earning per share of the Company is Rs. 0.24.

j) Accounting for Taxes on Income.

In accordance with the AS-22, Accounting for Taxes on Income, issued by the Institute of Chartered Accountants of India, deferred tax resulting from timing differences between book and tax profits is accounted for, at the current rate of tax, to the extent the timing differences are expected to crystallize. The deferred tax asset arising on account of brought forward unabsorbed depreciation is recognized only to the extent there is a reasonable certainty of realization.

k) AS – 28 Impairment of Assets.
As on the Balance Sheet date the carrying amounts of the assets net of accumulated depreciation is not less than the recoverable amount of those assets. Hence there is no impairment loss on the assets of the company.

In the opinion of Board of Directors, the Current Assets, Loans and advances have a value which on the realization in the ordinary course of business would at least be equal amount stated in the Balance sheet.

l) With regard to loan given to Company, the Board of Directors are of the opinion that no  interest should be provided in the accounts as the principle amount has not been recovered, Further, no provision for doubtful debt is required to be made as the amount is expected to be recovered in due course.

m) Deferred Tax :
The break up of the deferred tax liability as at 31st March, 2012 is as under:

	2011-12 Rupees	2010-11 Rupees
Deferred Tax Liability :
Difference between book depreciation and depreciation as per Income Tax Act, 1961.	63,62,909	64,30,675
	63,62,909	64,30,675
Deferred Tax Assets:	32,62,792	29,46,695
Net Deferred Tax  Liability	31,00,117	34,83,980

     

n) The Share Capital includes 4,00,000 Equity Shares of Rs. 10/- each, allotted as fully paid   Bonus Shares  by capitalisation of Capital Reserves in 1994-95.

o) Additional information pursuant to the provisions of paragraph 3, 4C and 4D of Part II of   Schedule VI  to the Companies Act, 1956, as certified by the Directors.Quantitative and Turnover information  for the year ending 31st March, 2012.(Previous year figures are regrouped wherever necessary

i] Manufacturing  Activities :                                                                                                 [Rupees in Lacs]

			Opening Stock			Closing Stock		Turnover
Class	Units	Actual production	Qty.	Value	Qty.	Value	Qty.	Value
Tablets	Nos.	121.859	37.990	50.27	41.890	54.09	117.959	188.74
	in Lacs	137.800)	(26.500)	(52.41)	(37.990)	(50.27)	(126.31)	(179.10)
Capsules	Nos.	83.684	22.790	60.56	15.594	54.08	90.88	324.44
	in Lacs	(99.870)	(12.030)	(35.74)	(22.790)	(60.56)	(89.11)	(252.59)
Liquids	Ltrs.	21090.180	5605.770	16.88	7697.560	27.34	18998.39	68.53
		(19051.160)	(5384.400)	(12.12)	(5605.770)	(16.88)	(18829.79)	(58.53)
Ointments	Kgs	3051.73	1256.330	17.88	1385.855	21.58	2922.205	45.59
		(3739.535)	(816.025)	(14.68)	(1256.330)	(17.88)	(3299.23)	(49.59)

 

Notes :

• Installed capacity is based on one shift working as certified by the management and  accepted by the  Auditors without verification being a technical matter.

• Actual production includes production under Loan License arrangements.

• Figures in brackets are of previous year.

ii] Particulars of Goods Traded:                                                                                              [Rupees in Lacs]

Class	Units	Opening Stock		Purchases		Sales		Closing Stock
		Qty.	Value	Qty.	Value	Qty.	Value	Qty.	Value
Liquids	Ltrs.	483.200	1.24	7253.000	13.28	5591.400	18.69	2144.800	6.67
	in Lacs	(979.200)	(2.53)	(4124.200)	(7.67)	(4620.200)	(14.32)	(483.200)	(1.24)
Injectables	Nos.	70.646	7.45	-	-	70.646	8.84	-	-
	in Lacs	(13.860)	(2.87)	(134.606)	(6.74)	(77.820)	(10.98)	(70.646)	(7.45)
Capsules	Nos.	1.750	5.69	9.167	17.49	9.732	37.69	1.185	3.84
	in Lacs	(0.530)	(1.73)	(8.580)	(16.04)	(7.360)	(30.60)	(1.750)	(5.69)
Tablets	Nos.	1.000	2.65	4.804	3.80	3.434	12.02	2.370	7.05
	in Lacs	(3.880)	(11.61)	-	-	(2.880)	(7.65)	(1.000)	(2.65)

 

iii] The quantity and value of consumption of raw materials

Raw Materials (Bulk Drugs)			Quantity (Kgs.)		Value (Rupees in Lacs)
			2011-12	2010-11	2011-12	2010-11
1	Calcium Pantothenate		456	462	3.39	3.04
2	Vitamin E		330	368	5.90	8.81
3	Meclizine		250	180	20.34	13.58
4	Paracetamol		2150	2450	4.98	6.61
5	Chlorazoxazone		425	300	3.68	1.64
6	Isox suprine Hcl		17	17	2.67	2.15
7	Riboflavin  ( B2)		92	75	2.39	3.74
8	Niacinamide		382	430	2.44	3.45
9	Thiaminemono (B1)		74	80	1.18	1.67
10	Spirulina		4156	2829	22.29	13.77
11	Clindamycin Phosphate		25	5	2.43	1.09
12	Progesterone		150	125	23.92	18.10
13	Menthol		175	170	2.75	1.97
14	Propylene Glycol		1635	1590	2.13	2.54
15	Sorbitol		2227	600	1.16	0.24
16	Fish Oil		360	160	3.63	1.42
17	Folic Acid		90	-	2.82	-
18	Sugar		12550	7500	3.85	2.17
19	P V P K		150	-	1.22	-
20	Ofloxacin usp		120	95	3.20	1.88
21	Quinine Sulphate		25	30	1.71	2.03
22	Mat SR Base III		84	106	1.49	1.76
23	Ornidazole		300	237	3.26	2.26
24	Empty Gelatin Capsule				10.75	10.39
25	Others				23.09	18.62
	Total :				156.67	122.93

 

---

As per our report of even date attached.
FOR  S. V. BHAT & CO.	FOR AND ON BEHALF OF THE BOARD.
Chartered Accountants.
S. V. BHAT	Dr.  L. S. Mani	Chairman & Managing Director
Proprietor.	N. K. MENON	Director
M. No. 37237 . FIRM REG.NO.101298W
Mumbai
Date:15th May, 2012.

 

(Top)